News
Telehealth company Hims & Hers is facing a growing number of U.S. investor lawsuits after Novo Nordisk's decision last month to end a short-lived partnership to sell its Wegovy weight-loss drug ...
Hims & Hers Health Inc. board members and executives failed to tell shareholders that its Novo Nordisk A/S Wegovy ...
Cheaper versions of medications to treat obesity, like Ozempic and Wegovy, could be on the market in Canada as soon as ...
Wegovy, a weight loss drug, is gaining popularity for its effectiveness, but experts emphasize that it's most successful when ...
Relying on Ozempic or Mounjaro to keep your weight in check can result in other issues, such as muscle wastage instead of fat ...
Weight loss jabs such as Wegovy and Mounjaro may offer a protective effect against dementia and stroke, according to a new ...
Explore more
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. The ...
WEIGHT loss jabs could boost men’s sex lives, a study suggests. Research found injections like Wegovy and Mounjaro can raise ...
Weight-loss injections, including popular drugs like Wegovy and Mounjaro, may offer a protective shield against serious conditions such as dementia and stroke, a new study has indicated. The research ...
The brain busting side-effects of Ozempic-like fat jabs revealed – ‘slashing risk of silent killers’
THEY’VE been hailed as miracle weight-loss jabs – but the effects of Ozempic-style drugs could go far beyond the waistline. New research suggests these so-called “skinny pens” may also ...
According to a new feature by the Washington Post, approximately 16 million American adults are on GLP-1 drugs such as ...
Research indicates GLP-1 receptor agonists, like Ozempic, may elevate testosterone levels in men while promoting weight loss.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results